Skip to main content
IMPEDIMED LIMITED logo

IMPEDIMED LIMITED — Investor Relations & Filings

Ticker · IPD ISIN · AU000000IPD8 LEI · 254900I3YH2IS1UEHJ67 ASX Manufacturing
Open in API
Filings indexed 1,549 across all filing types
Latest filing 2023-12-17 Director's Dealing
Country AU Australia
Listing ASX IPD

About IMPEDIMED LIMITED

https://www.impedimed.com

ImpediMed Limited is a medical technology company specializing in the development and commercialization of non-invasive devices utilizing bioimpedance spectroscopy (BIS) technology. The company's core focus is the early detection and management of secondary lymphedema in oncology patients, particularly those undergoing treatment for breast cancer. Its flagship product, the SOZO digital health platform, provides rapid and precise measurements of extracellular fluid, total body water, and body composition. Beyond oncology, the technology is applied to the clinical monitoring of chronic heart failure and other conditions characterized by fluid imbalance. By delivering actionable data through its BIS technology, ImpediMed enables clinicians to implement early interventions and personalized care strategies. The platform is designed for seamless integration into clinical workflows to support longitudinal patient assessment.

Recent filings

Filing Released Lang Actions
Change of Director's Interest Notice - Ms Janelle Delaney 2 pages 154.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's change in shareholding, including the number of shares acquired, disposed, and held after the change. The document is a formal notification of a director's personal share transactions, specifically an on-market trade. It does not contain financial statements or company performance data, nor is it an announcement of a report or a general regulatory filing. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is 3208 characters, consistent with a detailed insider trading notice rather than a full report or announcement.
2023-12-17 English
Change of Director's Interest Notice - Ms Emmanuel-Donnelly 2 pages 156.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details a director's change in relevant interests in securities, including the number of shares held before and after the change, the nature of the interest, and the transaction details. There is no financial performance data, earnings information, or report content. This matches the definition of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades). The document length is 3419 characters, which is consistent with a detailed notice rather than a full report or announcement. Therefore, the correct classification is DIRS (Director's Dealing).
2023-12-13 English
Application for quotation of securities - IPD 6 pages 27.2KB
Share Issue/Capital Change Classification · 95% confidence The document is an application for quotation of securities on the ASX, specifically relating to securities previously issued under an employee incentive scheme where transfer restrictions have ceased. It details the number and type of securities to be quoted, issue dates, and issued capital following quotation. This is a formal announcement related to capital changes, specifically the quotation of securities, which aligns with announcements about share issues or capital changes. It is not a financial report, earnings release, or management discussion. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length and content confirm it is not merely a brief announcement but a detailed application for quotation, supporting this classification with high confidence.
2023-12-12 English
Change of Director's Interest Notice - Ms Janelle Delaney 2 pages 154.7KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details a director's acquisition of shares, including the number of shares acquired, the price, and the nature of the transaction (on-market trade). The document is a formal notification of a director's personal share transactions, which aligns with the definition of Director's Dealing filings. The document length is 3166 characters, which is typical for such notices and not a full financial report or announcement of a report. Therefore, the document is best classified as a Director's Dealing report.
2023-12-06 English
Revised Security Trading Policy 18 pages 419.1KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 06 December 2023 regarding the revised Security Trading Policy of ImpediMed Limited. It contains detailed policy text about insider trading laws, prohibited trading periods, and procedures for directors and key management personnel regarding trading company securities. There is no financial data, earnings information, or report publication notice. The content is a regulatory announcement about governance and compliance related to securities trading by insiders. This fits best under Regulatory Filings (RNS) as it is a compliance-related announcement and does not constitute a financial report, management report, or governance report per se. The document length is substantial and contains the full policy text, not just a brief notice or summary, but it is not a financial or management report.
2023-12-05 English
Change of Director's Interest Notice - Mr Andrew Grant 2 pages 154.0KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details a director's acquisition of shares, including dates, number of shares, and transaction nature. This matches the description of a Director's Dealing report, which reports personal share transactions by company directors and executives. The document length is short and focused solely on this transaction, with no financial statements or broader company information. Therefore, it fits the 'Director's Dealing' category (DIRS).
2023-12-05 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.